November 01, 2006
1 min read
Save

Twelve-year Follow-up of Photorefractive Keratectomy for Low to Moderate Myopia

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

PURPOSE

To evaluate long-term safety and stability in a group of myopic patients who underwent photorefractive keratectomy (PRK) >12 years ago.

METHODS

Myopic PRK was performed on 120 eyes of 80 patients using the Summit UV200 excimer laser with a 5-mm ablation zone. Of the original group, most of whom were followed for >2 years (mean 2.6±1.7 years), 34 patients (58 eyes) returned at 12 years (mean 12.7±0.79 years) and had refractive stability, refractive predictability, best spectacle-corrected visual acuity (BSCVA), corneal haze, and subjective patient symptoms, such as glare/halos, recorded.

RESULTS

Preoperative mean refractive spherical equivalent (MRSE) ranged from –1.75 to –7.25 diopters (D) and astigmatism from 0.00 to 1.50 D. All eyes underwent a change in manifest refraction over 12 years. At 2 years, MRSE was –0.27±0.55 D and at 12 years was –0.58±0.72 D. In 87.9% of eyes, the level of preoperative BSCVA was maintained or improved, whereas 34.5% of eyes gained one line, and 12.1% lost one line of BSCVA. Uncorrected visual acuity >20/20 was noted in 67% of eyes, whereas 62.1% were within ±0.50 D of emmetropia. Trace haze was noted in 17.2% of eyes at 12 years. One patient had a rhegmatogenous retinal detachment, but this was unlikely due to the PRK procedure. With respect to the small optical zone, 14 (41.1%) patients had night visual problems, particularly halos, which were severe in 2.7%. All patients questioned stated they would have the procedure done again.

CONCLUSIONS

Photorefractive keratectomy with the Summit UV200 excimer laser effectively reduced myopia and showed good refractive stability from year 2 to 12 with good patient satisfaction. [J Refract Surg. 2006;22:871-877.]

AUTHORS

From Mater Private Hospital, Dublin, Ireland.

The authors have no financial or proprietary interest in the materials presented herein.

Correspondence: Michael O’Keeffe, FRCS, Mater Private Hospital, Eccles St, Dublin 7, Ireland. Tel: 353 1 8858626; Fax: 353 1 8858490; E-mail: mokeefe@materprivate.ie

Received: October 20, 2005

Accepted: June 27, 2006